- Home
- MBIO vs ICCT Comparison
MBIO vs ICCT Comparison
Compare MBIO & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBIO
- ICCT
- Stock Information
- Founded
- MBIO 2015
- ICCT 1992
- Country
- MBIO United States
- ICCT United States
- Employees
- MBIO N/A
- ICCT N/A
- Industry
- MBIO Biotechnology: Pharmaceutical Preparations
- ICCT Computer Software: Prepackaged Software
- Sector
- MBIO Health Care
- ICCT Technology
- Exchange
- MBIO Nasdaq
- ICCT Nasdaq
- Market Cap
- MBIO 7.3M
- ICCT 6.7M
- IPO Year
- MBIO N/A
- ICCT N/A
- Fundamental
- Price
- MBIO $1.22
- ICCT $2.60
- Analyst Decision
- MBIO Strong Buy
- ICCT
- Analyst Count
- MBIO 1
- ICCT 0
- Target Price
- MBIO $100.00
- ICCT N/A
- AVG Volume (30 Days)
- MBIO 1.0M
- ICCT 49.6M
- Earning Date
- MBIO 05-14-2025
- ICCT 05-14-2025
- Dividend Yield
- MBIO N/A
- ICCT N/A
- EPS Growth
- MBIO N/A
- ICCT N/A
- EPS
- MBIO N/A
- ICCT N/A
- Revenue
- MBIO N/A
- ICCT $11,049,477.00
- Revenue This Year
- MBIO N/A
- ICCT N/A
- Revenue Next Year
- MBIO N/A
- ICCT N/A
- P/E Ratio
- MBIO N/A
- ICCT N/A
- Revenue Growth
- MBIO N/A
- ICCT 42.66
- 52 Week Low
- MBIO $1.13
- ICCT $0.24
- 52 Week High
- MBIO $65.00
- ICCT $27.80
- Technical
- Relative Strength Index (RSI)
- MBIO 35.82
- ICCT 49.97
- Support Level
- MBIO $1.13
- ICCT $1.84
- Resistance Level
- MBIO $1.38
- ICCT $3.57
- Average True Range (ATR)
- MBIO 0.12
- ICCT 1.24
- MACD
- MBIO 0.04
- ICCT -0.17
- Stochastic Oscillator
- MBIO 33.33
- ICCT 11.95
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.